Portfolio News
Sofinnova Industrial Biotech
AFYREN announces its 2026 half-year financial results
- A strengthened industrial profile and a strategy focused on ramping up production
- AFYREN confirms its status as an industrial "pure player" with the 100% buyout of its plant
- Plant optimization program: successful June 2026 improvement works
- Progress in industrial proficiency, with increasing production and billings
- A value-creating commercial strategy
- A differentiated and certified offering, aligned with the industry's megatrends
- Secured market outlets, with potential for price revaluation
- A proactive financial policy supporting industrial development
- Financing of the buyout and operations of AFYREN NEOXY in the first half of 2026
- Cash position of €17.3 million as of June 30, 2026
Securing of €12.5 million in venture debt from BNP Paribas
- Confirmed short- and medium-term outlook
- Ambition to double AFYREN NEOXY's revenue in the second half of 2026 compared to the first half of 2026
- Confirmed objective to reach the plant's break-even point1, followed by the Group's break-even, on completion of the 2026–2027 investment program, before replicating the model on future plants
Clermont-Ferrand/Lyon, September 24, 2026, 05:45pm CEST - AFYREN, a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, today announces its half-year financial results for the period ended June 30, 2026, which have been subject to a limited review by the statutory auditors and approved by the Board of Directors on September 24, 2026.
Nicolas SORDET, CEO of AFYREN, states: “The first half of 2026 is a pivotal moment for AFYREN. We are taking charge of our industrial trajectory with 100% ownership of our pioneering plant and executing the performance investments that will lead to a significant increase in the volumes available to our customers. The intensification of the climate crises and the recurring disruptions to global supply chains call for a rethinking in the industry, in favor of companies like ours that offer local, circular, and decarbonized solutions.”
RECENT HIGHLIGHTS
AFYREN strengthens its position as an industrial "pure player" through the buyout of its plant from SPI In the first half of 2026, AFYREN completed the buyout of the 49% stake held by co-shareholder SPI (funds managed by Bpifrance on behalf of the French State under the Future Investment Programme - Programme d'Investissements d'Avenir) in the NEOXY plant for an amount of €11.3 million, paid in cash. This buyout, which reflects AFYREN's confidence in its industrial asset, enables the simultaneous pursuit of the plant's ramp-up and the investments required for its performance, with simplified governance and full alignment between the parent company and the plant. AFYREN is now an industrial company owning 100% of its plant and has all the levers to drive its ramp-up and achieve Group profitability starting from the first plant.
Learn more on the Afyren press release.
Related News
Qorium Becomes Reyva as Cultivated Leather Company Moves Towards Commercial Scale
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome
DMC secures $18M to expand health ingredients business
CorWave completes enrollment in feasibility study and presents first clinical data on adaptive support with its Wave Membrane LVAD
Muna Therapeutics announces positive Phase 1 results supporting potential of oral small-molecule TREM2 Modulator in Alzheimer’s disease